SCHEMBL247619

SCHEMBL247619

Nc1cc(Cl)cc(Cl)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29838724 1.00 — —
SCHEMBL3661086 0.85 — —
SCHEMBL190461 0.78 — —
SCHEMBL13884662 0.78 — —
SCHEMBL2034856 0.74 — —
SCHEMBL17923127 0.74 — —
SCHEMBL17923105 0.74 — —
SCHEMBL16603063 0.74 — —
SCHEMBL2185366 0.74 — —
SCHEMBL15542009 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225762-B1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMA (US) 2026-05-27 — — EP disclosed
US-12612416-B2 Modulators of cystic fibrosis transmembrane conductance regulator VERTEX PHARMACEUTICALS INCORPORATED (US) 2026-04-28 — — US disclosed
EP-4720057-A2 COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF Oncopia Therapeutics, Inc. D/B/A SK Life Science Labs (US) 2026-04-08 — — EP disclosed
EP-4694893-A1 NOVEL INHIBITORS OF PIKFYVE AND METHODS USING SAME TME Therapeutics LLC (US) 2026-02-18 — — EP disclosed
EP-4694981-A1 HETEROCYCLIC COMPOUNDS AS DUAL INHIBITORS OF PD-L1 AND ADENOSINE RECEPTORS Aurigene Oncology Limited (IN) 2026-02-18 — — EP disclosed
EP-4688778-A1 1H-PYRROLO[2,3-B]PYRIDIN-4-YL]-2-OXOPYRROLIDINE-3-CARBONITRILE DERIVATIVES AS TYROSINE KINASE 2 (TYK2) INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES Biogen MA Inc. (US) 2026-02-11 — — EP disclosed
EP-4680607-A1 BICYCLIC UREAS AS KINASE INHIBITORS Incyte Corporation (US) 2026-01-21 — — EP disclosed
EP-4673441-A1 LZK INHIBITORS Ureka Bioscienes, Inc. (US) 2026-01-07 — — EP disclosed
US-20250388541-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-12-25 — — US disclosed
US-20250388543-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-12-25 — — US disclosed
US-7108724-B2 Anti-pilling treating method for protein fiber material OKAMOTO CORPORATION (JP) 2006-09-19 — — US disclosed
US-20040261189-A1 Anti-pilling treating method for protein fiber material OKAMOTO CORPORATION (JP) 2004-12-30 — — US disclosed
CN-1044075-C Chinese herbal medicine plant pesticide and preparation method thereof LI YING (CN) 1999-07-14 — — CN disclosed
EP-0590685-B1 Process for optical resolution of (+)-cis-4-aminocyclopent-2-en-1-carboxylic acid derivative KURARAY CO (JP) 1996-05-29 — — EP disclosed
EP-0329170-B1 Process for producing 2-amino-4,6-dichloropyrimidine ISHIHARA SANGYO KAISHA (JP) 1995-06-21 — — EP disclosed
US-5371282-A Process for optical resolution of (+)-cis-4-aminocyclopent-2-en-1-carboxylic acid derivative KURARAY CO., LTD. (JP) 1994-12-06 — — US disclosed
EP-0590685-A1 Process for optical resolution of (+)-cis-4-aminocyclopent-2-en-1-carboxylic acid derivative KURARAY CO., LTD. (JP) 1994-04-06 — — EP disclosed
CN-1077193-A N-5 position-protected 2,5-diamino-4,6-dichloro pyrimidine and production method thereof LONZA AG (CH) 1993-10-13 — — CN disclosed
US-4929729-A REACTION WITH PHOSPHOROUS OXYCHLORIDE, HYDROLYSIS, CHLORINATION ISHIHARA SANGYO KAISHA LTD. (JP) 1990-05-29 — — US disclosed
EP-0329170-A2 Process for producing 2-amino-4,6-dichloropyrimidine ISHIHARA SANGYO KAISHA, LTD. (JP) 1989-08-23 — — EP disclosed
Send feedback